Under the NPCDCS framework, which of the following is the recommended screening interval for cardiovascular risk assessment at the primary health centre level in asymptomatic adults?

Explanation

## NPCDCS Cardiovascular Risk Screening Protocol **Key Point:** NPCDCS recommends **opportunistic screening every 5 years** for asymptomatic adults aged 30–65 years using simple, non-invasive risk assessment tools at the PHC level. **High-Yield:** The 5-year interval is based on the natural history of atherosclerosis and allows for timely intervention without excessive resource utilization. The focus is on **simple risk tools** (e.g., WHO/ISH risk prediction charts) rather than expensive laboratory investigations. ### NPCDCS Screening Strategy for CVD | Age Group | Screening Interval | Method | Setting | |-----------|-------------------|--------|----------| | **30–65 years** | Every 5 years | WHO/ISH risk charts, BP measurement | PHC/CHC | | **>65 years** | Every 2–3 years | Simple risk assessment | PHC/CHC | | **High-risk individuals** | Annual | Includes lipid profile, ECG if indicated | PHC/CHC or referral | **Clinical Pearl:** The program emphasizes **task-shifting** — ANMs and health workers can perform basic risk assessment using simple tools without requiring specialist involvement. **Mnemonic — CVD Screening in NPCDCS:** **5-30-65** = **5**-year interval for ages **30–65** years. **Warning:** Do not confuse NPCDCS screening intervals with international guidelines (e.g., ACC/AHA). NPCDCS is tailored for India's resource-limited primary care settings. [cite:Park 26e Ch 13]